Prelude Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-57,057
| Closed | -$1.36M | – | 1833 |
|
|
2021
Q1 | $1.36M | Buy |
+57,057
| New | +$1.36M | 0.04% | 281 |
|
|
2020
Q3 | – | Sell |
-440
| Closed | -$6K | – | 2058 |
|
|
2020
Q2 | $6K | Buy |
+440
| New | +$6K | ﹤0.01% | 1156 |
|
|
2020
Q1 | – | Sell |
-828
| Closed | -$4K | – | 1784 |
|
|
2019
Q4 | $4K | Sell |
828
-144
| -15% | -$696 | ﹤0.01% | 1312 |
|
|
2019
Q3 | $6K | Sell |
972
-1,654
| -63% | -$10.2K | ﹤0.01% | 1067 |
|
|
2019
Q2 | $17K | Buy |
2,626
+988
| +60% | +$6.4K | ﹤0.01% | 953 |
|
|
2019
Q1 | $12K | Sell |
1,638
-202
| -11% | -$1.48K | ﹤0.01% | 1038 |
|
|
2018
Q4 | $9K | Sell |
1,840
-25
| -1% | -$122 | ﹤0.01% | 1049 |
|
|
2018
Q3 | $14K | Buy |
+1,865
| New | +$14K | ﹤0.01% | 1044 |
|
|
2018
Q2 | – | Sell |
-3,248
| Closed | -$18K | – | 1781 |
|
|
2018
Q1 | $18K | Buy |
3,248
+2,648
| +441% | +$14.7K | ﹤0.01% | 1129 |
|
|
2017
Q4 | $3K | Buy |
+600
| New | +$3K | ﹤0.01% | 1158 |
|